Imunon, Inc.
IMNN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $167 | $165 | $2,165 | $165 |
| Gross Profit | -$167 | -$165 | -$2,165 | -$165 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,899 | $1,227 | $2,165 | $2,233 |
| G&A Expenses | $0 | $1,541 | $1,980 | $0 |
| SG&A Expenses | $1,410 | $1,541 | $1,980 | $1,748 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$165 | -$2,165 | $0 |
| Operating Expenses | $3,309 | $2,603 | $1,980 | $3,981 |
| Operating Income | -$3,476 | -$2,768 | -$4,145 | -$4,146 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $47 | $27 | $43 | $89 |
| Pre-Tax Income | -$3,429 | -$2,741 | -$4,102 | -$4,057 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,429 | -$2,741 | -$4,102 | -$4,057 |
| % Margin | – | – | – | – |
| EPS | -1.16 | -1.87 | -3.676 | -3.65 |
| % Growth | 38% | 49.1% | -0.7% | – |
| EPS Diluted | -1.16 | -1.87 | -3.676 | -3.65 |
| Weighted Avg Shares Out | 2,944 | 1,469 | 1,116 | 1,112 |
| Weighted Avg Shares Out Dil | 2,944 | 1,469 | 1,116 | 1,112 |
| Supplemental Information | – | – | – | – |
| Interest Income | $47 | $27 | $43 | $89 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | $167 | $165 | $67 | $165 |
| EBITDA | -$3,262 | -$2,576 | -$4,079 | -$3,892 |
| % Margin | – | – | – | – |